6228419

Teter J

1983

Plasma dehydroepiandrosterone sulfate and other androgens in normo- and hyperprolactinemic women with polycystic ovary disease.

6228420

Baranowska B

1983

[Analysis of the results of treatment of idiopathic hirsutism and hirsutism in patients with polycystic ovary syndrome with androcur (cyproterone acetate)].

6228873

Buvat J

1983

[Hormone levels, celioscopy and ovarian histology in the hirsutism-anovulation syndrome].

6229966

Carmina E

1984

Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern.

6230259

Shoupe D

1984

The influence of androgens on insulin resistance.

6232474

Raj SG

1984

Polycystic ovarian disease.

6233421

Milewicz A

1984

Prolactin levels in the polycystic ovary syndrome.

6234484

Seibel MM

1984

Bromocriptine response in normoprolactinemic patients with polycystic ovary disease: a preliminary report.

6234877

Holdaway IM

1984

Clinical and biochemical evaluation of patients with hirsutism.

6236073

Portuondo JA

1984

Periovarian adhesions following ovarian wedge resection or laparoscopic biopsy.

6237852

Piccione E

1984

[Clinical aspects of polycystic syndrome of the ovary: the behavior of salivary testosterone and estrone].

6237940

Coney P

1984

Polycystic ovarian disease: current concepts of pathophysiology and therapy.

6240943

Ola?e-Gberevbie FCh

1984

[Diagnostic value of laparoscopy in patients with infertility and oligomenorrhea].

6241119

Kim MH

1984

Chronic anovulation.

6249519

Apter D

1980

Serum steroids and pituitary hormones in female puberty: a partly longitudinal study.

6250118

Vovk IB

1980

[Endocrine methods of diagnosing sclerocystic ovarian degeneration in girls].

6252229

Rajaniemi HJ

1980

Luteinizing hormone receptors in ovarian follicles of patients with polycystic ovarian disease.

6254362

Lobo RA

1980

Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease.

6261995

Kandeel FR

1980

Adrenal function in subgroups of the PCO syndrome assessed by a long ACTH test.

6265489

Lobo RA

1981

Evidence for reduced 3 beta-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome.

6276736

Bedivan M

1981

[Endometrial carcinoma in the young woman. Its relations with ovarian lesions].

6281296

Chang RJ

1982

Circulating levels of plasma adrenocorticotropin in polycystic ovary disease.

6288518

Inaudi P

1982

Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.

6289691

Vulkov I

1982

[Current patholophysiologic and morphologic concepts of polycystic disease of the ovary].

6300163

Pittaway DE

1983

Human ovarian 17 beta-hydroxysteroid oxidoreductase activity: a comparison of normal and polycystic ovarian tissues.

6309433

Horrocks PM

1983

Acth function in women with the polycystic ovarian syndrome.

6311016

Bouallouche A

1983

Evidence for adrenal and/or ovarian dysfunction as a possible etiology of idiopathic hirsutism.

6311395

Chumas JC

1983

Malignant mixed M?llerian tumor of the endometrium in a young woman with polycystic ovaries.

6313730

Khan-Dawood FS

1983

Human ovaries contain immunoreactive oxytocin.

6320393

Guilmot JL

1983

[Virilizing luteoma of pregnancy. Relation to polycystic ovaries].

6326013

Wortsman J

1984

Elevated levels of plasma beta-endorphin and gamma 3-melanocyte stimulating hormone in the polycystic ovary syndrome.

6327404

Hoffman DI

1984

The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women.

6327799

Carmina E

1984

The endocrine pattern of late onset adrenal hyperplasia (21-hydroxylase deficiency).

6330631

Chetkowski RJ

1984

Origin of serum progestins in polycystic ovarian disease.

6332311

Milewicz A

1984

[A case of post-pubertal form of 21-hydroxylase deficiency and polycystic ovaries].

6333431

Grunberger G

1984

Tyrosine kinase activity of the insulin receptor of patients with type A extreme insulin resistance: studies with circulating mononuclear cells and cultured lymphocytes.

6340936

Schaff-Blass E

1983

Evaluation of women with hirsutism.

6344826

Wortsman J

1983

Glycosaminoglycan deposition in the acanthosis nigricans lesions of the polycystic ovary syndrome.

6347673

Baranowska B

1983

[Serum prolactin concentration after metoclopramide stimulation in patients with polycystic ovary syndrome].

6350118

Kaiser R

1983

[Current views on the epidemiology and etiology of endometrial carcinoma].

6351938

Hemmings R

1983

Pituitary and ovarian responses to luteinizing hormone releasing hormone in a rat with polycystic ovaries.

6353212

Futterweit W

1983

A case of bilateral dermoid cysts, insulin resistance, and polycystic ovarian disease: association of ovarian tumors with polycystic ovaries with review of the literature.

6356075

Mielecki T

1983

[Evaluation of ovarian phlebography in the polycystic ovary syndrome].

6356076

Brzezi?ska-Miszczyszyn T

1983

[Radiological image of the ovaries and adrenal glands in women with Stein-Leventhal syndrome].

6359918

Koval'ski? GB

1983

[Histophysiologic approaches underlying methods of correcting reproductive function in patients with the sclerocystic ovary syndrome].

6359919

Golubev VA

1983

[More precise definition of the indications for surgical treatment of patients with the sclerocystic ovary syndrome according to the results of the clomiphene test].

6359921

Sokolova TM

1983

[Menstrual and generative function after wedge-resection of sclerocystic ovaries in women of child-bearing age].

6360673

Shterev AD

1983

Serum LH-RH levels before and after ovarian wedge resection in polycystic ovary syndrome.

6364811

Lobo RA

1984

The control of bioactive luteinizing hormone secretion in women with polycystic ovary syndrome.

6365947

Meldrum DR

1984

Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women.

6368015

Presl J

1984

[The direct effect of insulin on the ovary and the pathogenesis of the polycystic ovary syndrome].

6372619

Rochiccioli P

1984

[Stein-Leventhal syndrome in adolescents. Study of a series of 34 cases].

6377641

Tucker M

1984

Infertility, megalocystic and polycystic ovaries: differential response to LHRH therapy.

6379174

Reindollar RH

1984

Pubertal aberrancy. Etiology and clinical approach.

6379175

Mansfield MJ

1984

Adolescent menstrual irregularity.

6383739

Pagel J

1984

Endometrial cancer. A review.

6391787

Nanji AA

1984

Disorders of gonadal function.

6396014

Liu JH

1984

The use of gonadotropin-releasing hormone for the induction of ovulation.

6400287

Geisth?vel F

1983

Ultrasonographic and endocrinological studies of ovarian function.

6400289

Goswamy RK

1983

Establishment of normal ranges for ovarian volumes and identification of enlarged ovaries by real-time mechanical sector sonar in postmenopausal women.

6401859

Puleo JG

1983

Nonpuerperal mastitis associated with galactorrhea.

6403570

Chang RJ

1983

Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist.

6405673

Rudd BT

1983

Urinary 17-oxogenic and 17-oxosteroids. A case for deletion from the clinical chemistry repertoire.

6406533

Tanabe K

1983

Levels of inhibin-F activity and steroids in human follicular fluid from normal women and women with polycystic ovarian disease.

6408837

Seifert B

1983

[Control of follicle maturation by estrogen determination in the serum and urine during treatment with gonadotropins].

6412573

Orenstein H

1983

Polycystic ovary disease in two patients with Briquet's disorder.

6413260

Kemmann E

1983

The initial experience with the use of a portable infusion pump in the delivery of human menopausal gonadotropins.

6415478

Vaitukaitis JL

1983

Polycystic-ovary syndrome--what is it?

6415804

Shterev AD

1983

FSH and LH responses to LH--RH stimulation during intravenous estrogen administration in women with polycystic ovary syndrome before and after ovarian wedge resection.

6415997

Burger CW

1983

Induction of ovulation by prolonged pulsatile administration of luteinizing hormone releasing hormone (LRH) in patients with clomiphene resistant polycystic ovary-like disease.

6416093

Bogdanova EA

1983

[Classification of amenorrhea in adolescent girls].

6416651

Lin SQ

1983

[Diagnosis and pathogenesis of polycystic ovary syndrome].

6419189

Venturoli S

1984

Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary.

6423658

Reid RL

1984

Gonadotropin-releasing activity of alpha-melanocyte-stimulating hormone in normal subjects and in subjects with hypothalamic-pituitary dysfunction.

6423671

Parisi L

1984

Polycystic ovarian disease: ultrasonic evaluation and correlations with clinical and hormonal data.

6424970

Spandri P

1984

Testosterone, 17 Ks, 17 beta E2 FSH-LH variations and hirsutism modifications during spironolactone therapy.

6424978

Spruce BA

1984

The effect of bromocriptine in the polycystic ovary syndrome.

6425087

Luciano AA

1984

Hyperprolactinemia in polycystic ovary syndrome.

6425436

Sugimura K

1984

[Studies on steroidogenesis of polycystic ovary syndrome--endocrinological analysis of follicular fluid and progesterone biosynthesis of cultured granulosa cells].

6426231

Venturoli S

1983

Induction of ovulation and pregnancy with HU-FSH (Metrodin) in women with polycystic ovarian disease: summary of clinical experience.

6426501

Molloy BG

1984

Pathological mechanisms in polycystic ovary syndrome: modulation of LH pulsatility by progesterone.

6429592

Garcea N

1984

Canalization of human cervical mucus.

6430730

Heineman MJ

1984

Hormonal characteristics of women with clinical features of the polycystic ovary syndrome.

6430731

Heineman MJ

1984

Pituitary and ovarian responses to LHRH stimulation in women with clinical features of the polycystic ovary syndrome.

6431037

Masaoka K

1984

[Induction of ovulation with pulsatile LHRH in anovulatory women].

6432730

Evron S

1984

Effect of spironolactone on testosterone and LHRH responsiveness in women with polycystic ovarian disease.

6435694

Schulster A

1984

Polycystic ovarian condition in estradiol valerate-treated rats: spontaneous changes in characteristic endocrine features.

6437227

Shoupe D

1984

Evidence for altered catecholamine metabolism in polycystic ovary syndrome.

6437878

Haning RV Jr

1984

Diagnosis-specific serum 17 beta-estradiol (E2) upper limits for treatment with menotropins using a 125I direct E2 assay.

6438220

Scirpa P

1984

Androstenedione, 17 beta-estradiol and progesterone plasma levels in gonadotropins induction of ovulation.

6438614

Baranowska B

1984

[Effect of dopamine on gonadotropin and prolactin secretion in patients with polycystic ovary syndrome].

6439439

Murdoch AP

1984

The acute effects of a dopamine antagonist (domperidone) on luteinising hormone, follicule stimulating hormone, prolactin and thyrotrophin secretion in polycystic ovarian syndrome: differential effect of ovulation.

6440582

Pilotti L

1984

[Inappropriate gonadotropin secretion in the polycystic ovary syndrome].

6442450

Dargent D

1984

[Polycystic ovaries. Round table].

6448231

Rook A

1980

Aspects of cutaneous androgen-dependent syndromes.

6452293

Goldzieher JW

1981

Polycystic ovarian disease.

6454061

Mauvais-Jarvis P

1981

Hirsutism.

6454866

Wortsman J

1981

Evidence for the hypothalamic origin of the polycystic ovary syndrome.

6455637

Julesz J

1981

[Treatment of hyperandrogenism in women with cyproterone acetate].

6455891

M?hlnickel D

1981

[Stein-Leventhal syndrome. 1. Differential diagnosis by laparoscopy (author's transl)].